Cities can now achieve “what was once thought impossible”: cutting air pollution by 20–45% in little more than a decade. A new analysis has found that 19 cities, including London, San Francisco and Beijing, cut levels of both PM2.5 and nitrogen dioxide (NO2) by more than 20% since 2010, driven by measures such as cycle lanes, electric vehicles and restrictions on polluting traffic. The Guardian
https://www.theguardian.com/environment/2026/mar/12/london-san-francisco-and-beijing-achieve-remarkable-reductions-in-air-pollution
#ShareGoodNewsToo

Cities can now achieve “what was once thought impossible”: cutting air pollution by 20–45% in little more than a decade. 19 cities, including London, San Francisco and Beijing, cut levels of both PM2.5 and nitrogen dioxide (NO2) by more than 20% since 2010. buff.ly/hsm3JlY #ShareGoodNewsToo

London, San Francisco and Beij...

‘Truly spectacular’ drug for sleeping sickness simplifies treatment, raising hopes for eradication. European regulators have approved acoziborole, a new treatment for sleeping sickness that cures the disease with a single oral dose. The drug replaces complex regimens requiring hospitalisation, spinal taps and weeks of monitoring, making treatment far easier in remote regions. Experts say the breakthrough could help eliminate the disease this decade. https://www.science.org/content/article/truly-spectacular-drug-sleeping-sickness-simplifies-treatment-raising-hopes-eradication
#ShareGoodNewsToo

European regulators have approved acoziborole, a new treatment for sleeping sickness that cures the disease with a single oral dose. The drug replaces complex regimens requiring hospitalisation, spinal taps and weeks of monitoring. buff.ly/KX3Ld2B #ShareGoodNewsToo

‘Truly spectacular’ drug for s...

EU moves to end animal testing for detergents and surfactants. Under the revised Detergents Regulation, animal tests for this category will be prohibited from mid-2029, and only scientifically validated non-animal methods will be allowed to assess risks to human health and the environment. Eurogroup for Animals https://www.eurogroupforanimals.org/news/eu-takes-big-step-end-animal-tests-everyday-cleaning-products
#ShareGoodNewsToo

Adult smoking in the United States has dropped below 10% for the first time. New analysis of national survey data found that cigarette use fell from 10.8% of adults in 2023 to 9.9% in 2024 (about 25 million people) down from 42% in 1964. The shift has helped drive a long fall in cancer mortality, with the American Cancer Society estimating reduced smoking prevented nearly four million lung cancer deaths between 1970 and 2022. Gizmodo https://gizmodo.com/americas-smoking-habit-just-hit-a-wild-milestone-that-once-seemed-impossible-2000732807
#ShareGoodNewsToo

Adult smoking in the United States has dropped below 10% for the first time. The shift has helped drive a long fall in cancer mortality, with the American Cancer Society estimating reduced smoking prevented nearly 4 million lung cancer deaths between 1970 and 2022 buff.ly/UzfP4jC #ShareGoodNewsToo

America’s Smoking Habit Just H...

A Japanese company has received the green light to mass-manufacture a treatment for Parkinson’s that transplants stem cells directly into the brain. In a seven-person study no adverse effects were observed and more than half the participants showed some signs of recovery. Because the study was so small, the license is provisional: patients will continue to be monitored and if the drug proves dangerous, it will be withdrawn. https://parkinsonsnewstoday.com/news/japan-grants-conditional-approval-amchepry-parkinsons/
#ShareGoodNewsToo

A Japanese company has received the green light to mass-manufacture a treatment for Parkinson’s that transplants stem cells directly into the brain. A 7-person study no adverse effects were observed and more than half the participants showed some signs of recovery buff.ly/JdSnIAx #ShareGoodNewsToo

Japan grants conditional appro...

A new immunotherapy is showing rare promise against advanced prostate cancer, a disease long thought resistant to this kind of treatment. In an early trial of 58 men whose cancer no longer responded to standard care, 88% had only mild side effects; and five of 11 men with measurable tumours saw them shrink. The drug is designed to activate only inside the tumour, which may both reduce dangerous inflammation and require fewer doses. The Guardian https://www.theguardian.com/society/2026/feb/28/researchers-praise-stunning-results-of-new-prostate-cancer-treatment
#ShareGoodNewsToo